Q4 EPS Forecast for Encompass Health Decreased by Analyst

Encompass Health Co. (NYSE:EHC) – Analysts at Zacks Research cut their Q4 2025 EPS estimates for Encompass Health in a note issued to investors on Monday, November 11th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings per share of $1.15 for the quarter, down from their previous forecast of $1.18. The consensus estimate for Encompass Health’s current full-year earnings is $4.29 per share. Zacks Research also issued estimates for Encompass Health’s Q1 2026 earnings at $1.35 EPS and FY2026 earnings at $5.31 EPS.

Other equities research analysts also recently issued reports about the company. Stephens reaffirmed an “overweight” rating and issued a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. UBS Group lifted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Finally, Truist Financial reissued a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $101.19 on Wednesday. Encompass Health has a 1-year low of $63.59 and a 1-year high of $104.55. The firm has a fifty day simple moving average of $96.08 and a 200-day simple moving average of $90.07. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $10.19 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 1.36 and a beta of 0.88.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the business posted $0.86 EPS. The company’s revenue for the quarter was up 11.9% on a year-over-year basis.

Institutional Investors Weigh In On Encompass Health

Several large investors have recently modified their holdings of the stock. CIBC Asset Management Inc boosted its stake in Encompass Health by 3.5% in the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after buying an additional 100 shares in the last quarter. Commonwealth Equity Services LLC lifted its holdings in Encompass Health by 1.3% during the 2nd quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock valued at $845,000 after purchasing an additional 123 shares during the last quarter. V Square Quantitative Management LLC boosted its position in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. O Shaughnessy Asset Management LLC grew its stake in Encompass Health by 3.9% during the first quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company’s stock worth $351,000 after buying an additional 160 shares during the last quarter. Finally, Verdence Capital Advisors LLC raised its stake in shares of Encompass Health by 4.6% in the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock valued at $355,000 after acquiring an additional 160 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health announced that its board has authorized a share buyback plan on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to repurchase up to 5.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.67%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.